International Patent: COMPOSITION COMPRISING NICLOSAMIDE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR PREVENTING FORMATION OF PATHOLOGICAL EXTRACELLULAR MATRIX (ECM) OR ALLEVIATING OR IMPROVING PREFORMED PATHOLOGICAL EXTRACELLULAR MATRIX, AND ADMINISTRATION METHOD USING SAME

GENEVA, Aug. 14 -- CNPHARM CO., LTD filed a patent application (KR2026/002470) for “COMPOSITION COMPRISING NICLOSAMIDE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR PREVENTING FORMATION OF PATHOLOGICAL EXTRACELLULAR MATRIX (ECM) OR ALLEVIATING OR IMPROVING PREFORMED PATHOLOGICAL EXTRACELLULAR MATRIX, AND ADMINISTRATION METHOD USING SAME”. With publication no. WO/2026/169106, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/167

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....